The angiotensin receptor blocker, candesartan reduces atherosclerosis in a dose-dependent manner

被引：0
|
作者：
Johnstone, MT [1 ]
Perez, A [1 ]
Stewart, R [1 ]
Cole, D [1 ]
Weissberg, J [1 ]
Quist, W [1 ]
机构：
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2000年 / 35卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：294A / 294A
页数：1
相关论文
共 50 条
  • [1] Effects of high dose angiotensin II receptor blocker - comparison of Valsartan and Candesartan
    Ohishi, Mitsuru
    Ito, Norihisa
    Takagi, Takashi
    Terai, Minako
    Tatara, Yuji
    Shiota, Atsushi
    Hayashi, Norihiro
    Katsuya, Tomohiro
    Rakugi, Hiromi
    Ogihara, Toshio
    JOURNAL OF HYPERTENSION, 2006, 24 : 364 - 364
  • [2] The dose-dependent antihypertensive actions of olmesartan medoxomil, an angiotensin II (AT-II) receptor blocker
    Pugsley, MK
    Mire, DE
    Silfani, TN
    Gupta, S
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 121A - 121A
  • [3] Angiotensin II receptor blocker: Candesartan cilexetil
    Inada, Y
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 35P - 35P
  • [4] Candesartan cilexetil: An angiotensin II receptor blocker
    Stoukides, CA
    McVoy, HJ
    Kaul, AF
    ANNALS OF PHARMACOTHERAPY, 1999, 33 (12) : 1287 - 1298
  • [5] Regression of Atherosclerosis in Apolipoprotein E-Deficient Mice is Feasible Using High-Dose Angiotensin Receptor Blocker, Candesartan
    Hayashi, Kaori
    Sasamura, Hiroyuki
    Azegami, Tatsuhiko
    Itoh, Hiroshi
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2012, 19 (08) : 736 - 746
  • [6] Tie1 attenuation reduces murine atherosclerosis in a dose-dependent and shear stress-specific manner
    Woo, Kel Vin
    Qu, Xianghu
    Babaev, Vladimir R.
    Linton, MacRae F.
    Guzman, Raul J.
    Fazio, Sergio
    Baldwin, H. Scott
    JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (04): : 1624 - 1635
  • [7] Intraocular CNTF reduces vision in normal rats in a dose-dependent manner
    McGill, Trevor J.
    Prusky, Glen T.
    Douglas, Robert M.
    Yasumura, Douglas
    Matthes, Michael T.
    Nune, George
    Donohue-Rolfe, Kate
    Yang, Haidong
    Niculescu, Diana
    Hauswirth, William W.
    Girman, Sergej V.
    Lund, Raymond D.
    Duncan, Jacque L.
    LaVail, Matthew M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2007, 48 (12) : 5756 - 5766
  • [8] Candesartan: widening indications for this angiotensin II receptor blocker?
    Mendis, B.
    Page, S. R.
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (12) : 1995 - 2007
  • [9] Candesartan cilexetil: An angiotensin II-receptor blocker
    See, S
    Stirling, AL
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (08) : 739 - 746
  • [10] Aprotinin reduces nitric oxide production in vitro and in vivo in a dose-dependent manner
    Bruda, NL
    Hurlbert, BJ
    Hill, GE
    CLINICAL SCIENCE, 1998, 94 (05) : 505 - 509
12345